Vanguard Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,957,730
Closed -$25M 4646
2023
Q1
$25M Buy
5,957,730
+386,319
+7% +$2.01M ﹤0.01% 2495
2022
Q4
$33.5M Buy
5,571,411
+785,388
+16% +$4.29M ﹤0.01% 2370
2022
Q3
$27.9M Buy
4,786,023
+409,584
+9% +$2.55M ﹤0.01% 2482
2022
Q2
$26.1M Buy
4,376,439
+777,024
+22% +$3.98M ﹤0.01% 2518
2022
Q1
$16.8M Buy
3,599,415
+228,600
+7% +$682K ﹤0.01% 2874
2021
Q4
$8.36M Sell
3,370,815
-305,189
-8% -$747K ﹤0.01% 3322
2021
Q3
$10.8M Buy
3,676,004
+9,800
+0.3% +$26.7K ﹤0.01% 3195
2021
Q2
$9.16M Buy
3,666,204
+620,892
+20% +$1.49M ﹤0.01% 3251
2021
Q1
$8.86M Buy
3,045,312
+83,000
+3% +$271K ﹤0.01% 3215
2020
Q4
$9.54M Buy
2,962,312
+126,182
+4% +$420K ﹤0.01% 3019
2020
Q3
$6.1M Buy
2,836,130
+687,082
+32% +$877K ﹤0.01% 3046
2020
Q2
$2.49M Hold
2,149,048
﹤0.01% 3369
2020
Q1
$1.98M Buy
2,149,048
+633,374
+42% +$726K ﹤0.01% 3318
2019
Q4
$2.4M Buy
1,515,674
+178,869
+13% +$169K ﹤0.01% 3398
2019
Q3
$1.11M Buy
1,336,805
+280,851
+27% +$214K ﹤0.01% 3626
2019
Q2
$907K Sell
1,055,954
-448,342
-30% -$414K ﹤0.01% 3699
2019
Q1
$1.46M Buy
1,504,296
+1,802
+0.1% +$1.9K ﹤0.01% 3534
2018
Q4
$1.1M Sell
1,502,494
-885,336
-37% -$1.45M ﹤0.01% 3542
2018
Q3
$5.16M Sell
2,387,830
-1,021
-0% -$2.53K ﹤0.01% 3226
2018
Q2
$11.9M Buy
2,388,851
+235,987
+11% +$1.03M ﹤0.01% 2813
2018
Q1
$8.4M Buy
2,152,864
+1,301,983
+153% +$4.58M ﹤0.01% 2907
2017
Q4
$2.28M Sell
850,881
-225,168
-21% -$660K ﹤0.01% 3386
2017
Q3
$3.43M Buy
1,076,049
+322,670
+43% +$1.08M ﹤0.01% 3247
2017
Q2
$2.49M Sell
753,379
-59,119
-7% -$230K ﹤0.01% 3317
2017
Q1
$3.41M Buy
812,498
+53,343
+7% +$246K ﹤0.01% 3200
2016
Q4
$3.06M Buy
759,155
+22,883
+3% +$94.9K ﹤0.01% 3224
2016
Q3
$2.76M Sell
736,272
-27,575
-4% -$100K ﹤0.01% 3274
2016
Q2
$2.6M Sell
763,847
-68,938
-8% -$316K ﹤0.01% 3275
2016
Q1
$4.42M Buy
832,785
+168,861
+25% +$1.35M ﹤0.01% 3027
2015
Q4
$8.17M Buy
663,924
+70,483
+12% +$941K ﹤0.01% 2750
2015
Q3
$8.66M Buy
593,441
+32,774
+6% +$566K ﹤0.01% 2682
2015
Q2
$10.9M Buy
560,667
+23,582
+4% +$455K ﹤0.01% 2628
2015
Q1
$9.72M Buy
537,085
+77,814
+17% +$1.75M ﹤0.01% 2661
2014
Q4
$10.8M Buy
459,271
+42,533
+10% +$983K ﹤0.01% 2506
2014
Q3
$10.1M Buy
416,738
+32,280
+8% +$839K ﹤0.01% 2491
2014
Q2
$10.8M Buy
384,458
+12,652
+3% +$380K ﹤0.01% 2473
2014
Q1
$12.6M Buy
371,806
+124,869
+51% +$4.27M ﹤0.01% 2378
2013
Q4
$4.74M Buy
246,937
+19,926
+9% +$363K ﹤0.01% 2827
2013
Q3
$3.72M Buy
227,011
+10,899
+5% +$126K ﹤0.01% 2893
2013
Q2
$2.27M Buy
+216,112
New +$2.53M ﹤0.01% 3018

Other funds holding CTIC